MPT Fundamental Analysis & Score

Medical Properties Trust, Inc. Real Estate REIT - Healthcare Facilities
$3.01
Quote dated October 16, 2026
43/100
Caution

What this score covers. It is a fixed screen of five reported ratios with no valuation input, so a company can score highly while its valuation risk remains elevated. The full report scores valuation separately, as one of nine scored sections. How the score is calculated

View Plans
Page generated: October 18, 2026 at 00:02 UTC

Key Financial Metrics

Market Cap
$1.80B
P/E Forward
60.2x
Revenue Growth
1.9%
Gross Margin
95.9%
Net Margin
-2.7%
Return on Equity
-0.6%
Debt/Equity
2.16

Rule-Based Financial Screen Summary

Medical Properties Trust, Inc. (MPT) is a Real Estate company in the REIT - Healthcare Facilities industry. It has a 43/100 Caution score on our five-factor fundamentals screen. Key strengths include Gross Margin (95.9%). Areas to watch: Net Margin (-2.7%), Return on Equity (-0.6%). The score is a five-factor screen — revenue growth, gross margin, net margin, return on equity and debt-to-equity — each scored against fixed thresholds from a neutral starting point of 50 points. The full report scores nine sections, including moat, free cash flow, dilution and valuation, which this screen does not.

Revenue Growth: Moderate Gross Margin: Excellent Net Margin: Negative Return on Equity: Negative Debt/Equity: High Risk

This page score and the strengths and concerns above are produced by deterministic, rule-based calculations from the available third-party financial inputs documented below. AI does not choose the score, strengths, or concerns. Data and automated summaries can contain errors. This is not personalized investment advice. See our methodology and disclaimer.

How this page score was calculated

The calculation starts at 50 points and applies the five fixed adjustments shown below. Missing or invalid inputs contribute no adjustment. A finite provider-reported zero is treated as a measured value and evaluated against that input's displayed threshold. The pre-clamp result is 43; the published result is clamped to a minimum of 10 and maximum of 98, producing 43/100.

MPT score inputs and fixed adjustments
Input Displayed value Threshold applied Adjustment Data status
Revenue Growth 1.9% > 0% to 10% +4 Available
Gross Margin 95.9% > 50% +10 Available
Net Margin -2.7% 0% or lower -8 Available
Return on Equity -0.6% 0% or lower -5 Available
Debt/Equity 2.16 1.00 or higher -8 Available

Score bands

80 or higher: Strong Buy; 65–79: Buy; 50–64: Hold; below 50: Caution.

These are fixed names for score ranges. The score is not a success probability, recommendation, or forecast, and 80/100 does not mean an 80% chance of a gain.

Not included in this score

  • Peer results or relative peer ranking
  • Demand zones or liquidity
  • Technical momentum
  • News or market sentiment
  • DCF valuation or the downloadable report score

Sources, freshness, and limitations

This page was generated . The provider identifies the latest underlying financial period as June 30, 2026. The displayed market quote is dated October 16, 2026. Generation time is not the same as the date of the underlying filing or market observation.

Financial inputs may be delayed, restated, differently standardized by the data provider, or unavailable. Missing, invalid, or non-finite values receive no positive or negative adjustment rather than being estimated. A finite provider-reported zero is retained and evaluated against that metric's displayed threshold; it is not treated as missing. This can make a sparse-data score less informative. The screen does not capture every business, market, valuation, or portfolio risk, and investors can lose money.

What the full MPT report adds

The 43/100 on this page comes from a fixed screen of 5 ratios. The downloadable report is a separate analysis with its own score, built from 9 weighted sections.

This page: fixed screen

  • Revenue Growth
  • Gross Margin
  • Net Margin
  • Return on Equity
  • Debt/Equity

Each factor is scored against fixed thresholds from a starting point of 50 points. No factor prices the stock, so valuation is not part of the 43/100.

Full report: 9 scored sections

  1. Business Moat weight 15 of 100
  2. Revenue Growth Consistency weight 14 of 100
  3. Margin Quality weight 12 of 100
  4. Free Cash Flow Strength weight 12 of 100
  5. Balance Sheet Safety weight 12 of 100
  6. Returns on Capital weight 12 of 100
  7. Dilution vs Self-Funded Growth weight 8 of 100
  8. Valuation vs Growth weight 10 of 100
  9. Structural vs Cyclical Growth weight 5 of 100

When the inputs allow, the report also shows a fair-value estimate with its discounted cash flow (DCF) assumptions and a 3×3 sensitivity table, a confidence figure, and the data limitations that reduced that confidence. Its headline label can add a valuation-risk flag next to the fundamental-quality rating.

Open the MPT report page

Supplementary Metrics for MPT

5 data points drawn from analyst targets, consensus estimates, and ownership data. These are supplementary observations, not event predictions or causal explanations:

The provider-reported analyst mean target is $5.12 (+70.3% from the displayed price), based on 6 estimates. This is third-party opinion, not a StrongBuyAnalytics target.
The provider-reported third-party analyst consensus category is None; it is not a StrongBuyAnalytics recommendation.
The current provider record reports institutional ownership of 63.1%.
The current provider record reports a short ratio of 13.2 days to cover.
The current provider record reports a dividend yield of 11.96%.

Risk Indicators for MPT

6 measurable indicators visible in Medical Properties Trust, Inc.'s reported numbers. These are market and valuation risk metrics — not a comprehensive list of business risks, which would require qualitative analysis beyond this data:

Net Margin (-2.7%)
Return on Equity (-0.6%)
Debt/Equity (2.16)
The provider-reported beta is 1.49. A beta above 1 reflects larger historical price moves relative to the provider's benchmark, but it does not predict future volatility or drawdowns.
The provider-reported short ratio is 13.2 days to cover. Short-interest data can be delayed and may reflect hedging or other strategies, so it does not establish investor intent or future direction.
The reported debt-to-equity ratio is above 1. Higher leverage can increase sensitivity to weaker cash flow or higher borrowing costs, but the ratio requires company and industry context.

MPT Balance Sheet & Cash Flow

Medical Properties Trust, Inc.'s liquidity and cash generation as of the most recent filing — note the cash position of $396.56M against $9.70B of debt:

Total Cash
$396.56M
Total Debt
$9.70B
Current Ratio
1.17
FCF Yield
41.9%
EBITDA
$948.78M
Operating Margin
57.4%

These are provider-normalized figures and may differ from the issuer's as-filed presentation, units, or latest amendment. Use source filings for verification.

MPT Valuation Snapshot

Forward P/E
60.2x
Price / Book
0.4x
Below asset value
PEG Ratio
1.61
Fairly valued
Analyst Target (Mean)
$5.12
Range: $4 – $7
Dividend Yield
11.96%
5Y avg: 8.70%
52-Week Price Range — MPT is trading at 0% of its range
$3.00 (52W Low) $6.47 (52W High)

Who Holds MPT? — Institutional 13F Filings

Institutional investment managers with >$100 M in qualifying assets must disclose their equity positions quarterly on SEC Form 13F — typically within 45 days of quarter-end. Search those filings below to see which hedge funds, mutual funds, and asset managers reported MPT as a holding, how many shares they held, and how positions changed quarter over quarter.

Search 13F Filings for MPT Free · no sign-in required · live SEC EDGAR data
What you see free
Which institutions reported MPT, share counts, reported values, and direct links to the SEC filing.
Research Pro adds
Full manager portfolios — every position a fund holds, quarter-over-quarter changes, and concentration weights.
Data limitation
13F reports covered long positions for the filing's stated reporting period, typically a quarter-end—not on its later submission date. Short positions, full derivatives, and current intent are not disclosed.

How to Interpret the MPT Fundamentals Score

MPT rates 43/100 on our five-factor fundamentals screen, which puts it in the "Caution" band. The band name describes a fixed range in this model; it is not a recommendation or prediction. The calculation above shows how each reported input affected the result.

43/100 · Caution band

Medical Properties Trust, Inc. falls short on several of the measures we weight most heavily. Specifically: net margin (-2.7%), return on equity (-0.6%). A low score reflects reported fundamentals only — it says nothing about the share price or about turnarounds already underway but not yet in the filings.

MPT Earnings & Revenue Outlook

Medical Properties Trust, Inc. reported revenue growth of 1.9% year over year, against a REIT - Healthcare Facilities peer set where scale and pricing power vary widely. Growth that slow contributes little to the score on its own; margins and capital efficiency carry more weight for MPT.

Track upcoming report dates on our earnings calendar.

MPT Fundamental Factors to Monitor

This is a review of reported fundamentals, not a price target or an estimate of future returns. These are the current figures that may be useful to monitor as new filings become available.

Lower current reading: The score is weighed down by net margin (-2.7%) and return on equity (-0.6%). Changes in those reported figures, rather than share-price movement, would change this screen.

Positive Fundamental Inputs for MPT

These are the Medical Properties Trust, Inc. figures that push the score up, taken straight from the most recent reported financials:

  • Gross Margin (95.9%)

Negative Fundamental Inputs & Risks for MPT

These are the figures working against MPT in the same model:

  • Net Margin (-2.7%)
  • Return on Equity (-0.6%)
  • Debt/Equity (2.16)

Learn More About Stock Analysis

Free 14-Min Course
Instructor
StrongBuy Analytics
Fundamental Research Team
How to Read Your Research Report
14Min
15Chapters
FreeNo sign-up

See how the metrics on this MPT page — quality score, valuation, DCF scenarios, confidence labels, and data limitations — are organized in the downloadable research report.

Generate My Free MPT Report

Guides to the specific measures used in this MPT analysis:

Fundamental Analysis Guide

How the financial statements behind this page fit together.

Understanding P/E Ratio

What MPT's forward multiple does and does not tell you.

Return on Equity (ROE)

Why MPT's -0.6% return on equity matters for stock selection.

Stock Valuation Methods

How DCF, multiples and asset-based approaches value a company like Medical Properties Trust, Inc..

DCF Assumptions and Limitations

What a discounted cash flow estimate for MPT depends on, and where it breaks down.

How to Read an AI Stock Report

What each section of a MPT report is for, and what it leaves out.

How to Read Earnings Reports

Where the MPT growth and margin figures on this page come from.

What Are Demand Zones?

The technical side we deliberately keep out of the MPT score.

Related Tools for MPT

Semiconductor Demand Zone Tracker MPT Live Chart MPT SEC Filing News Earnings Calendar Institutional Ownership Sector Scanner Average Down Calculator

MPT SEC Filing News

Latest SEC filings for MPT explained in plain English — insider buys/sells (Form 4), proposed sales (Form 144), material events (8-K), and quarterly & annual reports.

Loading recent SEC filings…
View all MPT SEC Filing News →

Frequently Asked Questions about MPT

Support and resistance are technical levels, so they are not part of the fundamentals score. Our demand zones page tracks semiconductor stocks; coverage does not extend to every ticker. Use the chart tool to identify price levels for MPT manually.

This MPT analysis is for educational and informational purposes only and does not constitute financial advice. Figures come from third-party feeds and can be delayed, standardized, incomplete, or inaccurate; verify material facts in primary filings and identified sources. Past performance does not guarantee future results. Read our full disclaimer.